Cargando…

Case series: Inflammatory myofibroblastic bladder tumor in regional Australia

INTRODUCTION AND IMPORTANCE: Inflammatory myofibroblastic tumor (IMT) is a rare tumor subtype that affects multiple organ systems. This case series adds a regional perspective to the literature, demonstrating rare urological cancers can be managed excellently in regional settings. CASE PRESENTATION:...

Descripción completa

Detalles Bibliográficos
Autores principales: Cresser, Sam, Nzenza, Tatenda, Tripathy, Sagarika, Hall, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113722/
https://www.ncbi.nlm.nih.gov/pubmed/33957398
http://dx.doi.org/10.1016/j.ijscr.2021.105898
_version_ 1783690923410980864
author Cresser, Sam
Nzenza, Tatenda
Tripathy, Sagarika
Hall, Rohan
author_facet Cresser, Sam
Nzenza, Tatenda
Tripathy, Sagarika
Hall, Rohan
author_sort Cresser, Sam
collection PubMed
description INTRODUCTION AND IMPORTANCE: Inflammatory myofibroblastic tumor (IMT) is a rare tumor subtype that affects multiple organ systems. This case series adds a regional perspective to the literature, demonstrating rare urological cancers can be managed excellently in regional settings. CASE PRESENTATION: We report a case series of two patients in regional Australia who were diagnosed with IMT of the urinary bladder. Both patients received computed tomography (CT) and ultrasound (US) imaging to investigate lower urinary tract symptoms (LUTS). Following initial diagnosis of a bladder tumor, both patients underwent surgery, one having a transurethral resection of bladder tumor (TURBT) with the other receiving a partial cystectomy. Histology from both surgeries revealed IMT of the urinary bladder, with the first case going on to receive a partial cystectomy to ensure clear surgical margins. Both patients recovered well post-operatively, with CT cystograms revealing water-tight bladders. Initial follow up reveals no recurrence of disease. CLINICAL DISCUSSION: IMT of the urinary bladder is an exceedingly rare clinical entity which is fortunately benign and can be well managed with appropriate surgical intervention. CONCLUSION: IMT can be well managed in regional hospitals equipped with appropriate surgical, pathological and oncological services.
format Online
Article
Text
id pubmed-8113722
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81137222021-05-18 Case series: Inflammatory myofibroblastic bladder tumor in regional Australia Cresser, Sam Nzenza, Tatenda Tripathy, Sagarika Hall, Rohan Int J Surg Case Rep Case Series INTRODUCTION AND IMPORTANCE: Inflammatory myofibroblastic tumor (IMT) is a rare tumor subtype that affects multiple organ systems. This case series adds a regional perspective to the literature, demonstrating rare urological cancers can be managed excellently in regional settings. CASE PRESENTATION: We report a case series of two patients in regional Australia who were diagnosed with IMT of the urinary bladder. Both patients received computed tomography (CT) and ultrasound (US) imaging to investigate lower urinary tract symptoms (LUTS). Following initial diagnosis of a bladder tumor, both patients underwent surgery, one having a transurethral resection of bladder tumor (TURBT) with the other receiving a partial cystectomy. Histology from both surgeries revealed IMT of the urinary bladder, with the first case going on to receive a partial cystectomy to ensure clear surgical margins. Both patients recovered well post-operatively, with CT cystograms revealing water-tight bladders. Initial follow up reveals no recurrence of disease. CLINICAL DISCUSSION: IMT of the urinary bladder is an exceedingly rare clinical entity which is fortunately benign and can be well managed with appropriate surgical intervention. CONCLUSION: IMT can be well managed in regional hospitals equipped with appropriate surgical, pathological and oncological services. Elsevier 2021-04-27 /pmc/articles/PMC8113722/ /pubmed/33957398 http://dx.doi.org/10.1016/j.ijscr.2021.105898 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Series
Cresser, Sam
Nzenza, Tatenda
Tripathy, Sagarika
Hall, Rohan
Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
title Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
title_full Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
title_fullStr Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
title_full_unstemmed Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
title_short Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
title_sort case series: inflammatory myofibroblastic bladder tumor in regional australia
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113722/
https://www.ncbi.nlm.nih.gov/pubmed/33957398
http://dx.doi.org/10.1016/j.ijscr.2021.105898
work_keys_str_mv AT cressersam caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia
AT nzenzatatenda caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia
AT tripathysagarika caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia
AT hallrohan caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia